EMA committee recommends approval of argenx's Vyvgart subcutaneous injection for chronic inflammatory demyelinating ...
argenx SE, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended …